PRCM
AGN

Pine River Capital Management’s Allergan plc AGN Stock Holding History

Pine River Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,125,000
Closed -$273M – 109
2017
Q2 		$273M Sell
1,125,000
-2,774,400
-71% -$652M 7% 6
2017
Q1 		$932M Buy
+3,899,400
New +$908M 18.43% 2

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Pine River Capital Management's AGN Position: Q4 2015 in Review

Pine River Capital Management sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 4,865 shares — an estimated $1.32M sold.

Pine River Capital Management first reported a position in AGN in Q2 2013 and held it in 3 quarters. The position peaked at $89.7M in Q3 2014. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Pine River Capital Management reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Pine River Capital Management sold 4,865 Allergan plc shares in Q4 2015, an estimated $1.32M.
  • Pine River Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 3 quarters.
  • Pine River Capital Management's Allergan plc position peaked at $89.7M in Q3 2014.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Pine River Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.